Pancreatic Cancer Research

ResearcherUniversity of TorontoActive in the last 2 years

Golam T. Saffi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 9 November 2026

Matched on ORCID iD 0009-0007-3936-2489; OpenAlex author ID A5068783946. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
4
Papers, trials and grants by year

2024: 1 paper · 2025: 2 papers · 2026: 1 paper

Papers 4

  1. Inositol Polyphosphate-4-Phosphatase Type II promotes gemcitabine resistance in pancreatic ductal adenocarcinoma cells via lysosomal exocytosis Co-author DOI 10.64898/2026.08.21.746312↗
  2. ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma. Co-author DOI 10.1002/1878-0261.70080↗
  3. The lipid phosphatase INPP4B controls pancreatic cancer cell migration and invasion by regulating fibronectin exocytosis. Co-author DOI 10.1016/j.jbc.2025.110716↗
  4. INPP4B promotes PDAC aggressiveness via PIKfyve and TRPML-1-mediated lysosomal exocytosis. Co-author DOI 10.1083/jcb.202401012↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Leonardo Salmena · 4 shared papers, 2024–2026 · strength 1.17
  2. Ché M.P. Melo · 3 shared papers, 2024–2026 · strength 0.74
  3. Daniel K.C. Lee · 1 shared paper, 2025 · strength 0.25
  4. Steve Gallinger · 1 shared paper, 2024 · strength 0.20

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.